The Impact of Early Dermatologic Events in the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib

The Impact of Early Dermatologic Events in the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib

Background and Aims. The presence of dermatologic reaction as an adverse event to sorafenib treatment in patients with unre-sectable hepatocellular carcinoma has been indicated as a prognostic factor for survival in a recent prospective analysis. To date, this is the only clinical predictor of treat...

Full description

Bibliographic Details
Main Authors: Fernanda Branco, Regiane S.M. Alencar, Fernanda Volt, Giovana Sartori, Andressa Dode, Luciana Kikuchi, Claudia M. Tani, Aline L. Chagas, Tulio Pfiffer, Paulo Hoff, Flair J. Carrilho, Angelo Alves de Mattos
Format: Article
Language:English
Published: Elsevier 2017-03-01
Series:Annals of Hepatology
Subjects:
Hepatocellular carcinoma
Overall survival
Dermatologic adverse events
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119303904

Internet

http://www.sciencedirect.com/science/article/pii/S1665268119303904

Similar Items